AVIR
Atea Pharmaceuticals Inc
Price:  
3.20 
USD
Volume:  
154,632.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Atea WACC - Weighted Average Cost of Capital

The WACC of Atea Pharmaceuticals Inc (AVIR) is 8.7%.

The Cost of Equity of Atea Pharmaceuticals Inc (AVIR) is 12.35%.
The Cost of Debt of Atea Pharmaceuticals Inc (AVIR) is 5.00%.

Range Selected
Cost of equity 10.70% - 14.00% 12.35%
Tax rate 0.50% - 1.70% 1.10%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.8% - 9.5% 8.7%
WACC

Atea WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.49 1.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.70% 14.00%
Tax rate 0.50% 1.70%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.8% 9.5%
Selected WACC 8.7%